Hawkins Matthew J. sold $2.1M of WAY

Hawkins Matthew J. (Chief Executive Officer) sold 82,500 shares of Waystar Holding Corp. (WAY) at $25.97 ($2.14M total) on 2026-09-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Hawkins Matthew J.
Published Sep 3, 2026, 5:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 3, 2026, 5:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$WAY
Neutral
medium confidence
Mentioned
$WAY
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$WAYNeutralLow
01

Why it matters

The disclosure provides incremental information about insider liquidity and potential sentiment, but it does not introduce new guidance, earnings, deals, or regulatory developments.

02

Market read

Traders may monitor for sentiment effects, but the 10b5-1 framing and lack of fundamental updates suggest low trading urgency.

03

What to watch

The filing does not clarify whether the sale is part of a larger multi-tranche program beyond stating it is pre-arranged; traders should compare with prior Form 4 patterns and total insider activity.

Relevance 5/10Novelty 5/10Timing: Filed on 2026-09-03, covering a sale executed on 2026-09-02.

Background

The article is a SEC Form 4 insider transaction disclosure for Waystar Holding Corp., reporting a CEO open-market sale executed under a Rule 10b5-1 plan.

Company-level read

Ticker impact

$WAYNeutralMedium confidence
Context

Waystar CEO Matthew J. Hawkins filed a Form 4 showing an open-market sale of 82,500 shares at $25.9707 on 2026-09-02 under a 10b5-1 plan.

Expected impact

Likely limited immediate price impact; any reaction should fade unless accompanied by other company-specific news.

Evidence & confidence

The filing is an open-market sale by the CEO with a pre-arranged 10b5-1 plan, which typically reduces signaling value versus discretionary sales. The article provides no new operational, financial, or regulatory catalyst.

Market effects

Minimal. Insider-sale disclosures generally do not reset sector expectations without accompanying fundamentals.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated or sizable CEO selling can still be interpreted by some traders as reduced confidence, especially if the stock is volatile.

Key entities

  • Waystar Holding Corp.

    Subject of the Form 4 insider transaction disclosure.

  • Matthew J. Hawkins

    Waystar CEO and director who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$WAYHighAI 8/10

Why is Waystar stock sliding today?

Waystar Holding Corp (WAY) stock fell 4.1% in pre-market trading after Q3 earnings. Revenue rose 21% YoY to $325.6M, and adjusted EPS of $0.44 beat estimates. However, full-year 2026 revenue guidance missed expectations, with a midpoint of $1.282B below the $1.29B consensus. Analysts raised price targets but cited concerns over Q4 growth deceleration.

$WAYHighAI 8/10

Waystar Holding Corp (WAY) Q3 2026 Earnings Call Highlights: Revenue Jumps 21% as AI Bookings Surge

Waystar Holding Corp (WAY) reported Q3 2026 revenue growth of 21% YoY, with adjusted EBITDA up 24% and a 43% margin. Bookings surged 25% YoY, including a major client win. AI innovations drove 43% of Q3 bookings. However, Q4 revenue growth is expected to slow to ~6%, with adjusted EBITDA declining sequentially due to top-line variability and AI investments. Iodine's performance-based pricing model delayed revenue recognition. Net revenue retention was 108%, at the lower end of historical range.

$WAYMed

Waystar: Q3 Earnings Snapshot

Waystar Holding Corp. (WAY) reported Q3 earnings of $31M, or 16 cents per share, beating estimates. Adjusted EPS was 44 cents. Revenue was $325.6M, also exceeding forecasts. The company expects full-year EPS of $1.63-$1.71 and revenue of $1.28B-$1.29B.

$WAYHighAI 8/10

What Waystar (WAY) Said on Its Q3 Earnings Call

Waystar (WAY) reported Q3 bookings for Iodine exceeded year-to-date plans by 74%, with $15M in Q3 bookings. The company launched an autonomous claim-resubmission feature, estimating it could resubmit up to $5B in rejected claims annually. Waystar lowered its full-year revenue forecast to $1.277B-$1.287B but raised adjusted EBITDA guidance to $543M-$549M. The company cited timing pressures for the revenue outlook adjustment.